Could a simple supplement help preterm babies breathe better?
NCT ID NCT07437391
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving L-carnitine, a natural substance, to premature babies with respiratory distress syndrome (RDS) can help them survive and gain weight better. Researchers will compare babies who get L-carnitine plus standard care to those who get standard care alone. The trial aims to enroll 160 preterm infants admitted to the NICU within 24 hours of birth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
L-carnitine
What this could lead to
If it works, this could point toward a simple, low-cost supplement to improve survival and weight gain in premature babies with breathing distress.
What could go wrong
This is a small, early-stage trial with no phase designation, so results are uncertain. The primary outcomes are limited to in-hospital death and weight change, not long-term health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Recep Tayyip Erdogan Hospital/Indus Hospital & Health Network
RECRUITINGMuzaffargarh, Punjab Province, 32400, Pakistan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact